PIIIP3 Health Partners Inc.

$5.24-36% 1Y

The financials

P3 Health Partners Inc. by the numbers

P3 Health Partners Inc. (PIII) reported revenue of $386M in Q2 2026 (quarter ended Jun 30, 2026), up 8.6% from the same quarter a year earlier. That came with net income of $7.4M (1.9% of revenue). For the full year FY2025, revenue was $1.46B (−2.8% year on year) and net income −$148M. Its largest product in Q2 2026 was Capitated at $366M, 90% of the disclosed total, well ahead of Health Care Patient Service at 4.9%. The next results filing is expected around Nov 13, 2026, the same week as a year ago.

P3 Health Partners Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Revenue$386M$356M+8.6%
Operating income$41M−$34Mto a profit
Net income$7.4M−$20Mto a profit
Diluted EPS−$0.63−$6.23n/a
Revenue by product, Q2 2026, as reported to the SEC
ProductRevenueShare
Capitated$366M90%
Health Care Patient Service$20M4.9%
Health Care Incentive Fees$10M2.6%
Health Care Care Coordination Management Fees$8.8M2.2%
Health Care Clinical Fees Insurance$856K0.2%

Business segments

Revenue split by product segment, from SEC XBRL filings.

Latest period: Jun 2026Total $406.4M (+3.3%)
Health Care Incentive Fees grew +1660% year on yearCapitated +4.2% year on year
  • Capitated$366.4Mquarter on quarter -3.5%year on year +4.2%
  • Health Care Patient Service$20.0Mquarter on quarter +190%year on year +392%
  • Health Care Incentive Fees$10.4Mquarter on quarter +9326%year on year +1660%
  • Health Care Care Coordination Management Fees$8.8Mquarter on quarter +34%year on year +228%
  • Health Care Clinical Fees Insurance$856.0Kquarter on quarter +225%year on year +5.9%
Segment sum = 105% of reported consolidated revenue · Latest source: 10-Q filed Aug 10, 2026, SEC EDGAR